The chemotherapy of plasma cell myeloma and related disorders.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010954:Plasmacytoma / Q000188:drug therapy; D011344:Procarbazine / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D011344:Procarbazine; D003520:Cyclophosphamide; D008558:Melphalan